Universidad Peruana Cayetano Heredia

Technologies for Diabetes Self-Monitoring: A Scoping Review and Assessment Using the REASSURED Criteria

Mostrar el registro sencillo del ítem

dc.contributor.author Zafra-Tanaka, Jessica Hanae
dc.contributor.author Beran, David
dc.contributor.author Vetter, Beatrice
dc.contributor.author Sampath, Rangarajan
dc.contributor.author Bernabé Ortiz, Antonio
dc.date.accessioned 2021-04-13T20:51:00Z
dc.date.available 2021-04-13T20:51:00Z
dc.date.issued 2021
dc.identifier.uri https://hdl.handle.net/20.500.12866/9162
dc.description.abstract BACKGROUND: Self-management is an important pillar for diabetes control and to achieve it, glucose self-monitoring devices are needed. Currently, there exist several different devices in the market and many others are being developed. However, whether these devices are suitable to be used in resource constrained settings is yet to be evaluated. AIMS: To assess existing glucose monitoring tools and also those in development against the REASSURED which have been previously used to evaluate diagnostic tools for communicable diseases. METHODS: We conducted a scoping review by searching PubMed for peer-review articles published in either English, Spanish or Portuguese in the last 5 years. We selected papers including information about devices used for self-monitoring and tested on humans with diabetes; then, the REASSURED criteria were used to assess them. RESULTS: We found a total of 7 continuous glucose monitoring device groups, 6 non-continuous, and 6 devices in development. Accuracy varied between devices and most of them were either invasive or minimally invasive. Little to no evidence is published around robustness, affordability and delivery to those in need. However, when reviewing publicly available prices, none of the devices would be affordable for people living in low- and middle-income countries. CONCLUSIONS: Available devices cannot be considered adapted for use in self-monitoring in resource constraints settings. Further studies should aim to develop less-invasive devices that do not require a large set of components. Additionally, we suggest some improvement in the REASSURED criteria such as the inclusion of patient-important outcomes to increase its appropriateness to assess non-communicable diseases devices. en_US
dc.language.iso eng
dc.publisher SAGE Publications
dc.relation.ispartofseries Journal of Diabetes Science and Technology
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject diabetes en_US
dc.subject monitoring devices en_US
dc.subject scoping review en_US
dc.subject self-monitoring en_US
dc.title Technologies for Diabetes Self-Monitoring: A Scoping Review and Assessment Using the REASSURED Criteria en_US
dc.type info:eu-repo/semantics/review
dc.identifier.doi https://doi.org/10.1177/1932296821997909
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.02.18
dc.relation.issn 1932-2968


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess

Buscar en el Repositorio


Listar

Panel de Control

Estadísticas